ChromaDex (CDXC) Reports In-Line Q4 EPS

ChromaDex (NASDAQ: CDXC) reported Q4 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $21 million versus the consensus estimate of $21.22 million.

GUIDANCE:

Looking forward, for the full year, the Company expects at least 10% revenue growth, with a realistic possibility of significantly greater growth this year

For earnings history and earnings-related data on ChromaDex (CDXC) click here.

You May Also Be Interested In

• Ennis (EBF) Reports In-Line Q1 EPS
• Robinhood plans $2B convertible notes offering due 2029
• Accenture (ACN) Tops Q3 EPS by 8c, Misses on Revenue; Offers FY26 EPS Guidance